Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
I
118TH CONGRESS
1ST SESSION H. R. 3703
To direct the Comptroller General of the United States to conduct and
complete a review examining the efforts of the Secretary of Health
and Human Services to ensure that the United States is prepared to
rapidly produce certain medical countermeasures in the event of a public
health emergency, and for other purposes.
IN THE HOUSE OF REPRESENTATIVES
MAY 25, 2023
Mr. LATTA (for himself and Ms. KELLY of Illinois) introduced the following
bill; which was referred to the Committee on Energy and Commerce
A BILL
To direct the Comptroller General of the United States to
conduct and complete a review examining the efforts
of the Secretary of Health and Human Services to ensure
that the United States is prepared to rapidly produce
certain medical countermeasures in the event of a public
health emergency, and for other purposes.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ‘‘Helping Evaluate Ap-
4
propriate Logistical Infrastructure for National Govern-
5
VerDate Sep 11 2014
04:19 Jun 17, 2023
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3703.IH
H3703
pbinns on DSKJLVW7X2PROD with $$_JOB
2
•HR 3703 IH
ment Response Act of 2023’’ or the ‘‘HEALING Response
1
Act of 2023’’.
2
SEC. 2. GAO REVIEW OF HHS EFFORTS TO ENSURE RAPID
3
PRODUCTION OF CERTAIN MEDICAL COUN-
4
TERMEASURES
IN
CASE
OF
A
PUBLIC
5
HEALTH EMERGENCY.
6
(a) IN GENERAL.—Not later than 1 year after the
7
date of the enactment of this Act, the Comptroller General
8
of the United States shall conduct and complete a review
9
examining the efforts of the Secretary of Health and
10
Human Services to ensure that the United States is pre-
11
pared to rapidly produce qualified countermeasures (as de-
12
fined in section 319F–1 of the Public Health Service Act
13
(42 U.S.C. 247d–6a)) in the event of a public health emer-
14
gency declared under section 319 of the Public Health
15
Service Act (42 U.S.C. 274d).
16
(b) CONTENTS.—The review conducted under sub-
17
section (a) shall include a review of—
18
(1) the efforts described in such subsection, in-
19
cluding the Secretary’s efforts to transition from the
20
Centers for Innovation and Advanced Drug Manu-
21
facturing program to any new efforts, including the
22
National Biopharmaceutical Manufacturing Partner-
23
ship and Industrial Base Expansion Connect;
24
VerDate Sep 11 2014
04:19 Jun 17, 2023
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H3703.IH
H3703
pbinns on DSKJLVW7X2PROD with $$_JOB
3
•HR 3703 IH
(2) the progress made toward the implementa-
1
tion of such efforts; and
2
(3) the planning within the Department of
3
Health and Human Services to assess risks and
4
challenges associated with advanced development
5
and manufacturing of qualified countermeasures.
6
(c) REPORT TO CONGRESS.—Not later than 1 year
7
after completing the review under subsection (a), the
8
Comptroller General of the United States shall submit to
9
the Congress a report containing—
10
(1) the results of the review; and
11
(2) the Comptroller General’s recommendations
12
for ensuring that the United States is prepared to
13
rapidly produce qualified countermeasures in the
14
event of a public health emergency.
15
Æ
VerDate Sep 11 2014
04:19 Jun 17, 2023
Jkt 039200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H3703.IH
H3703
pbinns on DSKJLVW7X2PROD with $$_JOB